Conflict of Interest
Charles L. Loprinzi reported financial relationships with Disarm Therapeutics, Asahi Kasei Metys Pharmaceuticals, NKMax, Novartis, Osmol Therapeutics, Nura Bio, HengRui Medicines, Genentech, OnQuality, Mitsubishi, Tanabe, and Pfizer. The other authors indicated no financial relationships.